Increasing Survival in Stage III NSCLC: Optimizing Care and Addressing New Clinical Challenges

In this online program experts discuss recent advances in the use of immunotherapy to optimize outcomes in patients with stage III NSCLC. Watch the on-demand Webcast and download the slides from a dynamic CCO symposium at the 2019 SITC Annual Meeting to learn more about how to integrate immunotherapies into your clinical practice.

Share

Program Content

Activities

Immunotherapy for Stage I-III NSCLC
Immunotherapy in Stage III and Earlier Stage NSCLC: Optimizing Care Today and Tomorrow
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 08, 2019

Expires: November 06, 2020

Faculty

cover img faculity

Roy S. Herbst, MD, PhD

Professor
Chief, Section of Thoracic Medical Oncology
Barnhart Family Distinguished Professor in Targeted Therapies
Department of Thoracic/Head and Neck Medical Oncology
Department of Cancer Biology
The University of Texas M. D. Anderson Cancer Center
Houston, Texas

cover img faculity

Melissa L. Johnson, MD

Assistant Professor
Division of Hematology/Oncology
Robert H. Lurie Comprehensive Cancer Center 
Northwestern University
Assistant Attending
Divison of Hematology/Oncology
Northwestern Memorial Hospital
Chicago, Illinois

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca